Recent Finacing
Recent Raise
OliLux Biosciences develops diagnostic and treatment‑monitoring tools for tuberculosis that rapidly distinguish active versus inactive infection, lower detection limits, detect drug resistance/susceptibility, and suit low‑resource settings.
